Clinical Trial Update: Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Clinical trial update describing a roll-over after a 3-year Phase 4 trial of tenofovir disoproxil fumarate for mild chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: E-DA Hospital | Conditions: Chronic Hepatitis B, Antiviral Treatment | Phase 4 | Status: UNKNOWN